Mr. Chris Jackson reports

MYM NUTRACEUTICALS ANNOUNCES ROB GIETL AS NEW CEO

The board of directors of MYM Nutraceuticals Inc. has unanimously voted to appoint Rob Gietl as its new chief executive officer. Mr. Gietl is well known for his ability to exponentially grow businesses, including the West Coast franchise expansion of Dominos Pizza, where he consistently grew the annual business to achieve 300-plus-per-cent increases year over year.

Mr. Gietl is a seasoned business development and operations executive with a diverse record of leading change across all areas of concept creation, brand repositioning, market penetration, fiscal accountability and efficient execution of business plans. He has grown business effectiveness in an array of sectors and circumstances throughout Canada, consistently aligned with stakeholders goals and values.

Mr. Gietl was most recently the director of business development at NRI Global Inc., where he headed up multimillion-dollar industrial acquisitions, environmental remediation, and global sales of reusable assets and commodities.

His skills in negotiations and plan development enabled him to leverage partnerships to accelerate expansion and facilitate synergy in execution.

MYM is very pleased to have Mr. Gietl on the team and believes his extensive experience in general management, marketing and innovation reinforces the company's bright future.

Mr. Gietl will be tasked with driving the expansion of new product offerings and building out new sales teams across the United States, Canada and internationally.

Mr. Gietl commented: "It is exciting to be joining this dynamic company which is on the verge of attaining fantastic milestones in this rapidly evolving industry. Our focus in the short term will be completing the buildout of our Quebec grow facility and expanding our HempMed product line sales network in Canada, the United States and internationally. We also have many new exciting products in our pipeline, examples ranging from CBD [cannabidiol] products, CBD beverages and ancillary businesses to the marijuana market."

Mr. Gietl further commented, "It is my mission, through aggressive growth, organically, acquisitions, additional product lines and new markets to bring the company to the top of our industry to benefit our customers and shareholders."

Mr. Gietl is replacing current chief executive officer Jonathan Fiteni, who now will be director of production operations and product development, in which he has very specialized experience. "The shareholders of this company are in good hands," commented Mr. Fiteni. "Mr. Gietl brings experience, passion and a unique approach to business our company can only benefit from. This is a huge win for our shareholders, and I look forward to working with Rob closely as we set out to build a truly great company. I want to thank my team for all their support over the years and look forward to being a part of a bigger, better MYM Nutraceuticals."

Pursuant to the executive agreement, MYM will issue 500,000 common shares to Mr. Gietl as a signing bonus. The company shall also issue the executive two million options to purchase common shares in the capital of the company at a price of 20 cents. The options shall vest quarterly over the two-year term of this agreement.

MYM is continuing to negotiate acquisitions of complementary businesses and assets in the technology, nutraceuticals and CBD nutraceutical sector and is currently in talks with other innovative companies.

About MYM Nutraceuticals Inc.

MYM Nutraceuticals' primary focus is developing high-end organic CBD and cannabis supplements and topical products. MYM also has an interest in the development of high-density farming facilities and technologies that allow MYM to expand its brand into the global market.

We seek Safe Harbor.